The Billion Cell Atlas, backed by Eli Lilly, MSD and AstraZeneca, maps mechanisms to support informed drug discovery.

Cancer immunity and immunotherapy research increasingly recognizes that chronic inflammation is a major driver of tumorigenesis, yet the complex and dynamic ...

London trio PVA weren't entirely sure what their ace new album meant, so they went to a tarot reader to see if she could help ...

A Binghamton professor and her students set out to "map American prejudice" and uncover historic racial covenants. See what ...

Archaeologists rarely expect clarity when surveying the ocean floor, since water tends to erase context rather than preserve ...

The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

Yet much about the landscape under the ice has been uncertain, because ground and air surveys are difficult in the region.

Illumina unveiled the Billion Cell Atlas, a large‑scale genetic perturbation dataset built with pharma partners to advance AI‑powered drug discovery, target validation, and disease biology.

Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, molecular modeling and automated research workflows.

Gene sequencing company Illumina on Tuesday introduced a dataset that maps genetic changes to help accelerate drug discovery ...

Many natural compounds that act on the human body provide active ingredients for medicines or clues for developing them, and ...

With no centralized, comprehensive map to navigate the underground labyrinth, unexpected subterranean findings have cost the ...